Biotech and medical business blog

Visit BioHealth Investor

ImClone Systems Starts Solid Malignancies & Lymphoma Trial Enrollment (IMCL)

Posted on June 25, 2008

ImClone Systems Inc. (NASDAQ: IMCL) has announced that its Phase 1 clinical trial of IMC-A12, itss fully human IgG1 anti-insulin-like growth factor-1 receptor monoclonal antibody plus the mTOR inhibitor temsirolimus, has opened for enrollment in patients with advanced solid malignancies and lymphoma.This study is being carried out at the M.D. Anderson Cancer Center in Houston, [...]...

Original article link


clinical trial , phase